加味二陈汤联合西药治疗稳定期慢性阻塞性肺疾病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:


Clinical Study on Modified Erchen Tang Combined with Western Medicine for Chronic Obstructive Pulmonary Disease at Stable Stage
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察加味二陈汤联合西药常规治疗稳定期慢性阻塞性肺疾病(COPD) 的临床疗效。方法:将86 例稳定期COPD 患者按照信封法随机分为研究组和对照组,各43 例,对照组采用常规西药治疗,研究组在对照组治疗的基础上给予加味二陈汤治疗。治疗3 个月后比较2 组临床疗效、肺功能及免疫功能改善情况。结果:治疗后,研究组总有效率为93.02%,对照组为76.74%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组第1 秒用力呼气量(FEV1)、第1 秒用力呼气量占用力肺活量百分比(FEV1/FVC)、FEV1 占预估值的百分比(FEV1%) 均较治疗前升高(P<0.05),且研究组各项指标均高于对照组(P<0.05)。治疗前,2 组CD3+、CD4+、CD8+、CD4+/CD8+水平比较,差异均无统计学意义(P>0.05)。治疗后,研究组CD3+、CD4+、CD4+/CD8+水平免疫功能较治疗前提升(P<0.05),并高于对照组(P<0.05);CD8+较治疗前降低(P<0.05),且低于对照组(P<0.05);而对照组CD3+、CD4+、CD8+、CD4+/CD8+水平治疗前后比较,差异无统计学意义(P>0.05)。结论:加味二陈汤联合常规西药治疗稳定期COPD,可有效改善患者临床症状及肺功能,提高机体免疫功能,疗效优于单纯西药治疗。

    Abstract:

    Abstract:Objective:To observe the clinical effect of modified Erchen tang combined with routine western medicine for chronic obstructive pulmonary disease(COPD) at stable stage. Methods:A total of 86 cases of patients with COPD at stable stage were randomly divided into the study group and the control group according to the envelope method,43 cases in each group. The control group was treated with routine western medicine, and the study group was additionally treated with modified Erchen tang based on the treatment of the control group. After three months of treatment,the clinical effect,the improvement of curative effect of lung function and immune function in the two groups was compared. Results: After treatment, the total effective rate was 93.02% in the study group and 76.74% in the control group, the difference being significant(P<0.05). After treatment,the values of FEV1,FEV1/FVC and FEV1% in the two groups were all increased when compared with those before treatment(P<0.05),and the above indexes inf the study group were higher than those in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of CD3+,CD4+,CD8+ and CD4+/CD8+ between the two groups(P>0.05). After treatment,the levels of CD3+,CD4+ and CD4+/ CD8+ of immune function in the study group were improved when compared with those before treatment(P<0.05),and the levels were higher than those in the control group(P<0.05);CD8 + in the study group was decreased when compared with that before treatment(P<0.05) and lower than that in the control group(P<0.05); in the control group, there was no significant difference being found in the comparison of the levels of CD3 + , CD4 + , CD8 + and CD4 +/CD8 + before and after treatment(P>0.05). Conclusion:The therapy of modified Erchen tang combined with routine western medicine for COPD at stable stage can effectively improve the clinical symptoms and lung function of patients as well as enhance the immune function,whose curative effect is better than that of simple western medicine.

    参考文献
    相似文献
    引证文献
引用本文

洪小兵,蒋梦霞,陈永青.加味二陈汤联合西药治疗稳定期慢性阻塞性肺疾病临床研究[J].新中医,2021,53(6):17-20

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-03-25
  • 出版日期:
文章二维码